IL103229A - History of imidazolylmethyl-pyridine, their preparation and pharmaceutical preparations containing them - Google Patents
History of imidazolylmethyl-pyridine, their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL103229A IL103229A IL10322992A IL10322992A IL103229A IL 103229 A IL103229 A IL 103229A IL 10322992 A IL10322992 A IL 10322992A IL 10322992 A IL10322992 A IL 10322992A IL 103229 A IL103229 A IL 103229A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- alkyl
- acid addition
- free base
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Luminescent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4131584A DE4131584A1 (de) | 1991-09-23 | 1991-09-23 | Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL103229A0 IL103229A0 (en) | 1993-02-21 |
| IL103229A true IL103229A (en) | 1996-09-12 |
Family
ID=6441240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10322992A IL103229A (en) | 1991-09-23 | 1992-09-21 | History of imidazolylmethyl-pyridine, their preparation and pharmaceutical preparations containing them |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0534904B1 (fr) |
| JP (1) | JP2568356B2 (fr) |
| KR (1) | KR100254085B1 (fr) |
| AT (1) | ATE144509T1 (fr) |
| AU (1) | AU650569B2 (fr) |
| CA (1) | CA2078700C (fr) |
| CZ (1) | CZ281675B6 (fr) |
| DE (2) | DE4131584A1 (fr) |
| DK (1) | DK0534904T3 (fr) |
| ES (1) | ES2092666T3 (fr) |
| FI (1) | FI103887B1 (fr) |
| GR (1) | GR3021444T3 (fr) |
| HU (2) | HUT61993A (fr) |
| IL (1) | IL103229A (fr) |
| MX (1) | MX9205365A (fr) |
| MY (1) | MY110450A (fr) |
| NO (1) | NO301162B1 (fr) |
| NZ (1) | NZ244420A (fr) |
| RO (1) | RO109337B1 (fr) |
| RU (1) | RU2058312C1 (fr) |
| SG (1) | SG43079A1 (fr) |
| SK (1) | SK289692A3 (fr) |
| TW (1) | TW222630B (fr) |
| ZA (1) | ZA927279B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10165349A (ja) * | 1996-12-06 | 1998-06-23 | Matsushita Electric Ind Co Ltd | 食器洗浄機 |
| DE10000161A1 (de) * | 2000-01-06 | 2001-07-19 | Boehringer Ingelheim Pharma | Verfahren zur Identifikation eines Proteaseinhibitors |
| GB0009037D0 (en) * | 2000-04-13 | 2000-05-31 | Novartis Ag | Organic compounds |
| US20080280954A1 (en) * | 2005-07-29 | 2008-11-13 | Vanda Pharmaceuticals, Inc | Method of Improving Wakefulness |
| EP1986659A4 (fr) * | 2006-02-13 | 2009-10-21 | Vanda Pharmaceuticals Inc | Compositions de dosage stables d'imidazolylalkylpyridines |
| WO2009097416A1 (fr) * | 2008-01-29 | 2009-08-06 | Vanda Pharmaceuticals, Inc. | Imidazolylalkyl-pyridines utilisées comme inhibiteurs de la dbh |
| EP2337788B1 (fr) | 2008-10-17 | 2016-03-23 | Wisconsin Alumni Research Foundation | Procédé de réalisation de peptides alpha-bêta biologiquement actifs |
| WO2012052540A1 (fr) * | 2010-10-21 | 2012-04-26 | Universitaet Des Saarlandes | Inhibiteurs sélectifs de cyp11b1 pour le traitement de maladies dépendantes du cortisol |
| WO2018217631A1 (fr) * | 2017-05-22 | 2018-11-29 | Torrey Pines Institute For Molecular Studies | Compositions, méthodes d'utilisation et méthodes de traitement |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862340D1 (en) * | 1978-02-01 | 1983-11-24 | Wellcome Found | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
| GB2028317B (en) * | 1978-08-15 | 1982-11-10 | Pfizer Ltd | 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors |
| US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
| DE3811574A1 (de) * | 1988-03-31 | 1989-10-19 | Schering Ag | N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1991
- 1991-09-23 DE DE4131584A patent/DE4131584A1/de not_active Withdrawn
-
1992
- 1992-09-09 HU HU9202886A patent/HUT61993A/hu unknown
- 1992-09-18 MY MYPI92001673A patent/MY110450A/en unknown
- 1992-09-21 SK SK2896-92A patent/SK289692A3/sk not_active IP Right Cessation
- 1992-09-21 CA CA002078700A patent/CA2078700C/fr not_active Expired - Fee Related
- 1992-09-21 CZ CS922896A patent/CZ281675B6/cs not_active IP Right Cessation
- 1992-09-21 FI FI924233A patent/FI103887B1/fi not_active IP Right Cessation
- 1992-09-21 DK DK92810719.2T patent/DK0534904T3/da active
- 1992-09-21 NZ NZ244420A patent/NZ244420A/xx not_active IP Right Cessation
- 1992-09-21 AU AU25226/92A patent/AU650569B2/en not_active Ceased
- 1992-09-21 SG SG1996003366A patent/SG43079A1/en unknown
- 1992-09-21 NO NO923653A patent/NO301162B1/no not_active IP Right Cessation
- 1992-09-21 IL IL10322992A patent/IL103229A/en not_active IP Right Cessation
- 1992-09-21 DE DE59207425T patent/DE59207425D1/de not_active Expired - Lifetime
- 1992-09-21 EP EP92810719A patent/EP0534904B1/fr not_active Expired - Lifetime
- 1992-09-21 ES ES92810719T patent/ES2092666T3/es not_active Expired - Lifetime
- 1992-09-21 AT AT92810719T patent/ATE144509T1/de active
- 1992-09-22 JP JP4252692A patent/JP2568356B2/ja not_active Expired - Fee Related
- 1992-09-22 KR KR1019920017228A patent/KR100254085B1/ko not_active IP Right Cessation
- 1992-09-22 RO RO92-01218A patent/RO109337B1/ro unknown
- 1992-09-22 MX MX9205365A patent/MX9205365A/es unknown
- 1992-09-22 RU SU925052552A patent/RU2058312C1/ru active
- 1992-09-23 ZA ZA927279A patent/ZA927279B/xx unknown
- 1992-09-24 TW TW081107550A patent/TW222630B/zh active
-
1995
- 1995-06-13 HU HU95P/P00198P patent/HU211261A9/hu unknown
-
1996
- 1996-10-24 GR GR960402593T patent/GR3021444T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1535379A3 (ru) | Способ получени 5-замещенных 2,4-диаминопиримидинов или их кислотно-аддитивных солей | |
| HU199425B (en) | Process for producing alpha-alkyl-/4-amino-3-quinolinyl/-methanols and 1-square brackets open 4-/aralkylamino/-3-quinolinyl square brackets closed -alkanones, as well as pharmaceutical compositions comprising such compounds as active ingredient | |
| EP0070562B1 (fr) | Dérivés d'ergoline, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| JPH0867670A (ja) | 置換４−フエニル−６−アミノ−ニコチン酸誘導体の薬剤としての利用 | |
| JPS61155358A (ja) | ジアリール酪酸誘導体 | |
| EP0483932A1 (fr) | Procédé pour la préparation de dérivés de la pipérazine | |
| IE62936B1 (en) | Arylthiazolylimidazoles as 5ht3 antagonists | |
| IL103229A (en) | History of imidazolylmethyl-pyridine, their preparation and pharmaceutical preparations containing them | |
| US5166181A (en) | Halogenoalkylphenyl-alcohols, ketones and hydrates thereof | |
| DE3851856T2 (de) | 1,4-Dihydropyridin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE69224507T2 (de) | Beta-Oxo-Beta-Benzenepropanthioamidderivate | |
| FR2549061A1 (fr) | Derives du spirosuccinimide utilisables comme medicaments | |
| US5258383A (en) | DC-89 derivatives | |
| US4556739A (en) | 3,4-Dialkoxy-2-alkylcarbonyl analino compounds | |
| US20020019427A1 (en) | Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof | |
| US20020061919A1 (en) | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one | |
| US5635521A (en) | Imidazolylmethyl-pyridines | |
| EP4206197A1 (fr) | Procédé de préparation d'un nouvel inhibiteur de protéine kinase liée à rho et d'un intermédiaire dans le procédé de préparation | |
| HU197878B (en) | Process for producing guanidino-benzoic acid esters and pharmaceutical compositions containing them | |
| GB2171997A (en) | 4-Amino-6,7-dimethoxy-2-Piperazin-1-ylquinazoline derivatives | |
| ES2912409T3 (es) | Intermedios y procesos para la preparación de linagliptina y sus sales | |
| CA1323876C (fr) | Derives de dihydropyridine; compositions pharmaceutiques a base de ces derives | |
| US4843085A (en) | Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics | |
| GB2101587A (en) | Methylenedioxybenzene derivatives. | |
| EP0122376B1 (fr) | Dérivés de la pyridine doués d'une activité anticholinestérase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| HC | Change of name of proprietor(s) | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |